Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
767.680.33%
QQQ
718.310.09%
BTC/USD
78571.780.6556%
DIA
529.760.81%
GLD
403.310.85%
TLT
81.940.33%

Tiziana Life Sciences Ltd

TLSANASDAQ
Trade with Public
Trade with Public
$1.02
0.04554.67%
At close: Sep 3, 5:00 PM EST
$1.01
0.03553.64%
Pre-Market: 5:03 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Tiziana Life Sciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Tiziana Life Sciences (TLSA).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$7Upside to Avg. PT+593.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 3, 2026BTIGThomas ShraderInitiateBuy$7

Analyst Ratings News

This Occidental Petroleum Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: Neutral COP; Buy TLSA ($7), OXY ($73), NRSN ($8); Sell SM ($35).
Avi Kapoor

PRO
BTIG Initiates Coverage On Tiziana Life Sciences with Buy Rating, Announces Price Target of $7

BTIG analyst Thomas Shrader initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Buy rating and announces Price Target of $7.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2022

Upgrades
Benzinga Insights

PRO
ThinkEquity Initiates Coverage On Tiziana Life Sciences with Buy Rating, Announces Price Target of $4

ThinkEquity initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Buy rating and announces Price Target of $4.
Benzinga Newsdesk

PRO
Tiziana Life Sciences Shares Spike Higher; Zacks Small-Cap Research Sets $7.50 Price Target

Benzinga Newsdesk

PRO
Zacks Investment Research Initiates Coverage On Tiziana Life Sciences with Not Rated Rating, Announces Price Target of $7.5

Zacks Investment Research analyst John Vandermosten initiates coverage on Tiziana Life Sciences (NASDAQ:TLSA) with a Not Rated rating and announces Price Target of $7.5.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved